BTK inhibitors
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.
Merck Sharp & Dohme Corp.
A A C C A A A A A C A A
A61P A61P C07D C07D A61K A61P A61P A61K A61P C07D A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Shuling Jian Shilan Hao Ronald M. Chundao
Zheng Liu Liu Wu Kim Yang